GleamWall
中文EN

FOCL EDAP TMS SA

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1041934 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin44.4%
Operating margin-31.8%
Net margin-42.8%
FCF margin—
EBITDA margin-27.4%

Returns

ROE-129.2%
ROA—
ROIC (approx.)-176.5%
Asset turnover—

Leverage & solvency

Liabilities / assets67.5%
Debt / equity0.99x
Current ratio2.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-31
Income statement
Revenue$9.83M$13.20M$17.81M$46.69M$7.83M$9.51M$14.27M
Cost of revenue$4.78M$5.87M$9.67M$28.36M$4.18M$4.65M$8.27M
Gross profit$5.05M$7.34M$8.15M$18.33M$3.65M$4.86M$5.99M
R&D expense$2.46M$2.32M$2.60M$2.71M$2.30M$2.29M$2.58M
SG&A expense$4.46M$5.52M$5.79M$6.84M$3.83M$3.90M$3.65M
Operating income-$7.78M-$8.03M-$7.37M-$4.66M-$6.67M-$6.62M-$6.31M
Pretax income-$5.27M-$14.40M-$8.94M-$8.05M-$6.64M-$6.34M-$7.30M
Income tax$15,000$8,000$145,000$399,000$16,000$14,000$144,000
Net income-$4.46M-$14.49M-$9.08M-$9.46M-$5.94M-$6.41M-$7.44M
EBITDA-$6.78M-$7.03M-$6.47M-$3.75M-$5.77M-$5.78M-$5.56M
EPS (basic)-0.10-0.39-0.24—-0.16-0.17-0.20
EPS (diluted)-0.10-0.39-0.24—-0.16-0.17-0.20
Weighted avg. shares (diluted)42.63M37.53M37.48M—37.44M37.42M37.39M
Balance sheet
Cash & equivalents$56.27M$21.54M$15.01M$20.45M$12.41M$19.06M$24.69M
Short-term investments———$0———
Receivables$10.18M$10.06M$19.65M$14.95M———
Inventory$8.33M$8.25M$13.33M$7.77M———
Current assets$94.78M$59.02M$50.36M$57.16M———
PP&E, net$9.05M$8.63M$10.20M$8.79M———
Goodwill$732,000$735,000$2.77M$757,000$757,000—$2.61M
Intangibles$1.82M$1.77M$1.72M$1.79M———
Total assets$110.72M$74.55M$72.06M$79.00M——$81.09M
Current liabilities$36.07M$36.85M$37.51M$37.14M———
Short-term debt$338,000$848,000$1.46M$2.08M———
Long-term debt$35.23M$37.20M$17.60M$15.90M———
Total debt$35.57M$38.05M$19.06M$17.98M———
Total liabilities$74.78M$77.77M$61.96M$59.58M———
Shareholders' equity$35.94M-$3.23M$10.10M$19.41M$22.08M$27.45M$37.27M
Net debt-$20.70M$16.50M$4.05M-$2.47M———
Shares outstanding47.22M37.53M37.48M37.48M———
Cash flow statement
Operating cash flow-$4.02M-$3.69M-$2.97M-$2.45M-$3.91M-$4.71M-$5.34M
Investing cash flow-$1.34M-$1.26M-$754,000-$1.71M-$1.08M-$1.61M-$1.30M
Financing cash flow$40.30M$11.77M-$1.37M$11.46M-$1.65M$56,000-$1.25M
Depreciation & amortization$998,000$1.01M$896,000$911,000$897,000$846,000$753,000

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.